Robert Spiegel

Dr. Robert J.
Spiegel, MD, is an Independent Director at RenovoRx, Inc., an Independent Director at Ayala Pharmaceuticals, Inc., an Independent Non-Executive Director at Sun Pharma Advanced Research Co. Ltd., a Venture Advisor at Israel Biotech Fund, an Associate Professor at Weill Cornell Medical College, an Independent Director at Geron Corp., an Advisor at Warburg Pincus & Company US LLC, a President at Spiegel Consultants, LLC and a Member at Blood Cancer United, Inc. He is on the Board of Directors at Ernexa Therapeutics, Inc., RenovoRx, Inc., Ayala Pharmaceuticals, Inc., Sun Pharma Advanced Research Co. Ltd., Geron Corp.
and Oncology Clinical Research & Development.
Dr. Spiegel was previously employed as an Independent Director by Athenex, Inc., a Vice Chairman by Cyclacel Pharmaceuticals, Inc., an Independent Director by Ayala Pharmaceuticals, Inc. /Old/, an Independent Director by Sucampo Pharmaceuticals LLC, an Independent Director by Edge Therapeutics, Inc., an Independent Director by Weifa ASA, a Chief Medical Officer by PTC Therapeutics, Inc., an Independent Director by Talon Therapeutics, Inc., an Independent Director by Capstone Therapeutics Corp., a Chief Medical Officer by Schering-Plough Research Institute, a Director-Developmental Therapeutics by New York University Medical Center, a Chairman by NexImmune, Inc., a Vice President-Clinical Research by Schering-Plough Corp.
USA, and a Chief Medical Officer & Senior Vice President by Worldwide Clinical Research, Inc. He also served on the board at Advaxis, Inc., Vidac Pharma Ltd., PDS Biotechnology Corp., Avior Computing Corp., Rutgers Cancer Institute of New Jersey, CancerCare of New Jersey and NexImmune, Inc. He received his undergraduate degree from Yale University and a doctorate degree from the University of Pennsylvania.